USING MOLECULAR MARKERS IL-3, IL-33 AND IL12Ρ40 TO CHARACTERIZE SEVERITY OF RESPIRATORY INFECTIONS CAUSED BY RESPIRATORY SYNCYTIAL VIRUS AND HUMAN METAPNEUMOVIRUS Russian patent published in 2019 - IPC C12Q1/68 C12Q1/70 

FIELD: biotechnology.

SUBSTANCE: invention relates to biotechnology and determination of respiratory diseases using molecular markers as a means of predicting the development of respiratory infections. Molecular markers gene expression profile can be determined in biological samples by ELISA, flow cytometry or PCR analysis in real time.

EFFECT: on the basis of confirming the aetiological factor of infection together with the determination of the profile of molecular markers IL-3, IL-33 and IL12p40, the severity of the disease will be predicted.

3 cl, 5 dwg, 1 tbl, 1 ex